Loading...

Basilea Pharmaceutica AG

BPMUFPNK
Healthcare
Biotechnology
$69.00
$0.00(0.00%)
U.S. Market is Open • 15:44

Basilea Pharmaceutica AG (BPMUF) Stock Competitors & Peer Comparison

See (BPMUF) competitors and their performances in Stock Market.

Peer Comparison Table: Biotechnology Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
BPMUF$69.00+0.00%846.9M9.69$7.12N/A
NONOF$43.40+3.01%193.3B12.05$3.61+4.19%
CSLLY$22.40-0.58%86.7B14.55$1.54+3.26%
UCBJY$135.12+0.69%51.4B28.72$4.70N/A
UCBJF$269.84-1.61%51.4B28.71$9.40N/A
ARGNF$724.55+0.00%44.8B37.04$19.56N/A
CMXHF$89.96+3.59%43.7B14.58$6.17+3.25%
WXIBF$4.70+0.00%19.4B27.65$0.17N/A
IVBXF$11.25+1.56%19.4B160.71$0.07N/A
WXXWY$8.55+1.03%17.4B24.80$0.34N/A
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

BPMUF vs NONOF Comparison May 2026

BPMUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BPMUF stands at 846.9M. In comparison, NONOF has a market cap of 193.3B. Regarding current trading prices, BPMUF is priced at $69.00, while NONOF trades at $43.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BPMUF currently has a P/E ratio of 9.69, whereas NONOF's P/E ratio is 12.05. In terms of profitability, BPMUF's ROE is +0.35%, compared to NONOF's ROE of +0.61%. Regarding short-term risk, BPMUF is less volatile compared to NONOF. This indicates potentially lower risk in terms of short-term price fluctuations for BPMUF.Check NONOF's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions